A bladder scanner is a noninvasive ultrasound device which produces a virtual 3D image of the bladder with urine volume. These devices provide quick and precise information which can be used in rapid diagnosis and treatment of several urological ailments and can also prevent unnecessary catheterization.
Read full research report :
Rise in Urological Complaints to Boost Bladder Scanner Demand
Bladder scanners are extensively used in hospitals/clinics, and diagnostic centers. The hospitals/clinics segment is expected to capture a major market share from 2017 to 2022 (forecast period). This growth can be associated with increased budget for healthcare services and availability of reimbursement policies for diagnosis procedures. These devices are extensively used in the hospitals for evaluating urinary retention, bladder volume and post-void residual volume (PVR) in postoperative patients with reduce urine output. It can be also used in diagnosing urinary tract infection (UTI), urinary incontinence, neurogenic bladder, and others.
For instance, LABORIE recently launched its 3D automatic bladder scanner called Portascan 3D. Its live pre-scan functionality finds the bladder and calculates the bladder volume. This unconventional product avoids additional catheterization and risk of UTIs (CAUTI). Ultrasound bladder scanners can be used in many circumstances including urology, acute care, and gynecology. It is a non-invasive substitute to urinary retention, intermittent catheterization used to assess (initial) bladder volume, and post-void residual volume (PVR).
Market Overview
According to a report made available by Radiant Insights, Inc.; the global bladder scanner market is anticipated to exhibit significant growth by 2022. Increasing prevalence of urological illnesses such as neurogenic bladder dysfunction, bladder cancer, overactive bladder, and others, is expected to induce market demand. Technological progressions in the medical field can propel the bladder scanner market growth during the forecast period (2017 to 2022). In addition, constant product approvals and improved medical compensation policies for urological preliminary tests can drive the market in the coming years.
Some of the leading companies operating in the market include Signostics Inc.; Laborie; Verathon Inc.; Medline Industries India Private Limited; and MCube Technologies Pvt. Ltd.
To get free sample request :
No comments:
Post a Comment